Obesity Trial, Recruiting NCT03663530 Sponsor: Columbia University Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT03663530
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People of any racial or ethnic background
  • People with a body mass index (a measure of height-to-weight ratio) between 20 and 34.9
  • People who sleep an average of 7 hours or more per night, as measured over a 2-week screening period
  • People who eat something within 1 hour of waking up on at least 5 days per week
  • People whose midpoint of sleep falls at 4 AM or earlier (for example, someone who sleeps from 10 PM to 6 AM, with a midpoint of 2 AM)

Who may not be able to join:

  • People who had fewer than 10 nights of at least 7 hours of sleep during the 2-week screening period
  • People who nap regularly during the day
  • People who have a current or past sleep disorder, or who score above 10 on a standard insomnia severity scale
  • People who have a current or past psychiatric condition, including eating disorders or seasonal affective disorder
  • People with any mental health condition that could interfere with the study results
  • People who currently smoke cigarettes, use tobacco products, e-cigarettes, or vapes, or who stopped smoking less than 3 years ago
  • People who work night shifts or rotating shifts
  • People who have travelled across time zones within 4 weeks before the study
  • People with a history of drug or alcohol misuse, or who regularly drink more than 3 alcoholic drinks per day (men) or more than 2 per day (women)
  • People whose weight has changed by more than 5% in the past 3 months, who are currently on a diet or weight loss program, or who have had any weight loss procedure
  • People who are pregnant or who gave birth less than 1 year ago
  • People who have been diagnosed with sleep apnea, or who score highly on a standard sleep apnea risk questionnaire
  • People with depression (based on a standard scoring scale) or who are taking antidepressant medications
  • People with restless leg syndrome or circadian rhythm disorders
  • People with dementia or cognitive impairments
  • People currently taking medications that affect mood, mental state, or sleep
  • People taking ongoing pain relief or anti-inflammatory medications
  • People who have had gastrointestinal surgery, including gastric bypass surgery
  • People with restricted or disordered eating patterns based on a standard eating behaviour questionnaire
  • People who are unable to have an MRI scan for any reason
  • People with a low red blood cell measure (haematocrit below 30%) (confirm with trial site)
  • People taking beta blocker medications, as these can interfere with a hormone involved in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marie-Pierre St-Onge, PhD, Columbia University

Phone: 212 305 9379

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 January 2019
Est. completion
31 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Energy expenditure; Body composition; Nutritional intakes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov